Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

De Giorgi V, Trane L, Savarese I, Silvestri F, et al. Lasting response after discontinuation of Cemiplimab in a patient with locally advanced basal cell carcinoma. Clin Exp Dermatol 2021 Jun 22. doi: 10.1111/ced.14804.
PMID: 34157152


Privacy Policy